Pfizer Animal Health Expands Global Commitment To A Safe FoodSupply With A New Focus On Healthy Fish, Pfizer Inc
Release Date: 2010-05-25
NEW YORK, N.Y., May 25 - Pfizer Animal Health today announced its acquisition of Microtek International, Inc., a recognized innovator in aquaculture vaccines, R&D and healthcare diagnostic services. The acquisition further expands Pfizer’s commitment to a safe food supply from healthy beef and dairy cattle, swine, poultry and, now, fish.Total global fish production – largely for human consumption – now exceeds that of pork, poultry, beef or dairy. Farmed fish production is becoming increasingly important in meeting global demand and is anticipated to account for 55% of total fish production by 2017, according to industry sources.
“The time is right for Pfizer Animal Health to enter the global market for aquaculture healthcare therapeutics,” said Juan Ramón
Alaix, president, Pfizer Animal Health. “The integration of Microtek R&D into Pfizer Animal Health also will allow us to build a more diverse and innovative portfolio in biopharmaceuticals. The meat, dairy, egg and fish products that people enjoy for healthy living begin with a healthy food animal.”
William Kay, Ph.D., president and chief executive officer, Microtek, who will continue to serve Pfizer in a consultant role, said, “Microtek not only brings to Pfizer Animal Health industryleading vaccines and technology, but also complements Pfizer’s portfolio of health services and diagnostics for food animal production.”
Terms of Pfizer Animal Health’s acquisition of Microtek were not disclosed.
| Type: | NORMAL |
| Company: | Pfizer Inc |
| Country: | United States of America |